Confidential mandate

Agentic-Underwriting Delegation Board Examiner — Commercial Insurance

Planned Hiring / New

Agentic-Underwriting Delegation Board Examiner mandate in London, United Kingdom · Commercial and Specialty Insurance

A London commercial insurer appoints a ten-month board examiner to challenge agentic underwriting delegation, tool use and accountability without carrying pricing, risk-acceptance, customer or executive authority.

The mandate

The board repeatedly asks where an underwriting agent may act rather than merely assist: collecting risk evidence, requesting missing data, calling pricing tools, proposing conditions, communicating with brokers or binding within delegated limits. Current pilots describe human oversight, but do not resolve cascading tool error, silent goal expansion, accumulated exceptions or which named underwriter owns a multi-step agent trajectory.

The examiner will reserve three days monthly for committee preparation, trajectory review and closed sessions with underwriting and model-risk leaders, and attend five London meetings. A written challenge on a declared agent action or control breach is due within one UK business day. Model validation, implementation, policy drafting or incident management requires separate authority.

This appointment runs for ten months from February 2027. During month eight, management will defend an unseen tool-compromise and delegated-limit scenario to the committee. One three-month renewal may be approved by full-board vote for a named product or regulatory decision; unused time expires and cannot become programme delivery or standing model supervision.

The examiner has no line authority, executive authority, underwriting authority, pricing right, binding permission, customer-communication mandate or model approval. Named underwriters and executives retain every risk decision, and formal control functions retain their opinions. Advice cannot be represented as acceptance of an agent, insurance risk, control framework or customer outcome.

Positions or interests involving insurers, brokers, coverholders, AI-agent platforms, underwriting software, model validators or major technology vendors must be disclosed as conflicts. One non-competing financial-services board role may continue with chair approval. Equity or contingent compensation tied to an evaluated agent vendor or underwriting portfolio is incompatible with this appointment.

Why the board wants this voice

Underwriters understand risk and AI engineers understand orchestration, but neither discipline alone has governed autonomous tool chains whose apparent task completion can cross a legal delegation boundary. The board wants someone who has constrained machine action in a consequential workflow without becoming the model approver, underwriting executive or vendor advocate.

What you will own

  • Press directors to trace objective, instruction, retrieved evidence, tool call, intermediate state, exception, human approval and external action.
  • Test delegation boundaries across product, territory, risk class, premium, wording, data quality, counterparty and accumulated portfolio exposure.
  • Challenge human-oversight claims when review occurs after an irreversible broker message, quote, binding step or downstream tool action.
  • Frame scenarios involving prompt injection, compromised tool, stale authority, goal drift, conflicting instructions and unavailable underwriter.
  • Probe whether logs support reconstruction of alternatives rejected, limits checked, evidence changed and the accountable person at each step.
  • Examine incentives that reward processing speed while shifting exception, conduct, concentration or correction cost outside the pilot metric.
  • Coach directors to separate technical task success, model assurance, delegated authority and valid underwriting judgement.

Candidate qualifications

  • Held senior underwriting, model-risk or autonomous-system governance authority in commercial insurance or another delegated financial market.
  • Governed multi-step AI or rules-based action across evidence retrieval, pricing tools, wording, referral and externally consequential communication.
  • Designed delegation limits that accounted for cumulative portfolio exposure, exception chaining and authority expiry rather than single transactions.
  • Challenged nominal human oversight where intervention occurred too late to prevent binding, conduct or customer consequences.
  • Presented agentic-system stop, scale and accountability choices to boards and regulators under competitive deployment pressure.
  • Managed conflicts across insurers, brokers, coverholders, AI platforms and validators while preserving confidential underwriting evidence.

Non-negotiables

  • Can attend all five London committee sessions and respond within one business day to a declared agent-control event.
  • Will disclose insurer, broker, coverholder, platform, software and model-validation interests before trajectory access.
  • Accepts literal absence of line, executive, underwriting, pricing, binding, customer and model-approval authority.
  • Must evidence constrained machine delegation in a consequential workflow; general responsible-AI policy work is insufficient.
  1. 49 words maximum. Describe an automated action that remained within a task but crossed the human owner’s actual delegation.
  2. 49 words maximum. Which current insurer, broker, coverholder, agent-platform or validation interests require disclosure?
  3. 49 words maximum. How would you test cumulative authority when individually permitted tool calls form one consequential trajectory?

This mandate is confidential. The client is named only under a mutual NDA, and your own record is never listed, sold or shown to a company under your name until you release it for this specific mandate.